Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems for use in any human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. It has two segments: the medical market and the veterinary market. It markets the blood analysis system in the medical market under the name Piccolo xpress. Blood analysis system in the veterinary market is marketed under the name VetScan VS2. Its primary product is a blood analysis system. In April 2009, the Company submitted an assay for C-Reactive Protein (CRP) to the United States Food and Drug Administration (FDA) for 510(k) clearance. In May 2009, it entered into a license agreement with Abbott Point of Care Inc., granting the Company the right to sell and distribute Abbott’s i-STAT 1 handheld instrument (i-STAT 1 analyzer) and associated consumables (for blood gas, electrolyte, basic blood chemistry and immunoassay testing) in the animal healthcare market worldwide.